Blackstone Sells 13.1% Stake In Emcure To Bain For $112 Million
This article was originally published in PharmAsia News
Executive Summary
A 13.1% stake in Emcure Pharmaceuticals has changed hands as the Blackstone private-equity firm sold its shares to Bain Capital for $112 million.